Division of Endocrinology and Diabetes

Medicine & Life Sciences

1. Breast Neoplasms 100%
2. Polyamines 63%
3. Eflornithine 40%
4. Tamoxifen 34%
5. Hormones 31%
6. Methylnitrosourea 29%
7. Androgens 28%
8. Estrogen Receptor Modulators 27%
9. Growth 25%
10. Neoplasms 23%
11. Prolactin 21%
12. Estrogens 21%
13. Estradiol 19%
14. Omega-3 Fatty Acids 18%
15. Ornithine Decarboxylase 16%
16. Insulin Resistance 15%
17. Hypophysectomy 15%
18. Polycystic Ovary Syndrome 14%
19. Obesity 14%
20. Testosterone 13%
21. Agar 13%
22. Breast 13%
23. Adrenocorticotropic Hormone 13%
24. Growth Hormone 12%
25. Fish Oils 12%
26. Progesterone 11%
27. Putrescine 11%
28. Thymocytes 11%
29. Estrogen Receptors 11%
30. Glucose 11%
31. Therapeutics 11%
32. Hyperglycemia 10%
33. B-Lymphocytes 10%
34. Spermidine 10%
35. In Vitro Techniques 10%
36. Ovariectomy 10%
37. Pancreatitis 10%
38. Adipose Tissue 9%
39. Weight Loss 9%
40. Cell Culture Techniques 9%
41. Spermine 9%
42. Ornithine 9%
43. Insulin-Like Growth Factor I 9%
44. Transforming Growth Factors 9%
45. Glucocorticoids 9%
46. Breast Density 9%
47. Insulin 9%
48. Intercellular Signaling Peptides and Proteins 9%
49. Gastric Bypass 9%
50. Thymus Gland 8%
51. Adenosylmethionine Decarboxylase 8%
52. Type 2 Diabetes Mellitus 8%
53. Drug Therapy 8%
54. Gonadotropin-Releasing Hormone 7%
55. human AR protein 7%
56. Insulin-Like Growth Factor Binding Proteins 7%
57. Cell Line 7%
58. Docosahexaenoic Acids 7%
59. Serum 7%
60. Conditioned Culture Medium 7%
61. Adipocytes 7%
62. Small Cell Lung Carcinoma 7%
63. Messenger RNA 7%
64. Castration 7%
65. Raloxifene Hydrochloride 7%
66. Clinical Decision Support Systems 7%
67. Progesterone Receptors 7%
68. Neoplasm Metastasis 6%
69. Glucocorticoid Receptors 6%
70. Genes 6%
71. Aminoglutethimide 6%
72. Biomarkers 6%
73. 4-amidinoindan-1-one 2'-amidinohydrazone 6%
74. Type 1 Diabetes Mellitus 6%
75. Prolactin Receptors 6%
76. Randomized Controlled Trials 6%
77. Carcinogenesis 6%
78. Prostatic Neoplasms 6%
79. Chronic Pancreatitis 5%
80. Phenotype 5%
81. Proteins 5%
82. Ornithine Decarboxylase Inhibitors 5%
83. T-Lymphocytes 5%
84. Bariatric Surgery 5%
85. MCF-7 Cells 5%
86. Orchiectomy 5%
87. Clusterin 5%
88. Hormone Antagonists 5%
89. Sheep 5%
90. Somatomedins 5%
91. Perphenazine 5%
92. Omacor 5%
93. Epithelial Cells 5%
94. Chemoprevention 5%
95. Ligands 5%